Concepedia

Publication | Open Access

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial

DOIFull Paper Access

50

Citations

20

References

2020

Year

Kentaro Yamazaki, Takeharu Yamanaka, Manabu Shiozawa, Dai Manaka, Masahito Kotaka, Makio Gamoh, Akio Shiomi, Akitaka Makiyama, Yoshinori Munemoto, T. Rikiyama,
Annals of Oncology

Abstract

UMIN Clinical Trials Registry, UMIN000013036 and Japan Registry of Clinical Trials, jRCTs031180128.

References

YearCitations

Page 1